These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38507316)

  • 1. Left ventricular hypertrophy. Is there only hypertrophic cardiomyopathy?
    Lluch-Requerey C; Montilla-Garrido MA; Morgado-García-Polavieja JI; Gragera-Martínez Á; Gómez-Menchero A
    Arch Cardiol Mex; 2024; 94(1):123-126. PubMed ID: 38507316
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinguishing hypertension from hypertrophic cardiomyopathy as a cause of left ventricular hypertrophy.
    Pennacchini E; Musumeci MB; Fierro S; Francia P; Autore C
    J Clin Hypertens (Greenwich); 2015 Mar; 17(3):239-41. PubMed ID: 25582947
    [No Abstract]   [Full Text] [Related]  

  • 3. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.
    Maron MS; Lesser JR; Maron BJ
    Am J Cardiol; 2010 Jun; 105(12):1842-3. PubMed ID: 20538141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of Left Ventricular Hypertrophy in a Case of Adult Hypertrophic Cardiomyopathy: Importance of Clinical Context at Initial Diagnosis.
    Liang Z; Ananthakrishna R; Selvanayagam JB
    Heart Lung Circ; 2022 Nov; 31(11):e151-e152. PubMed ID: 35981934
    [No Abstract]   [Full Text] [Related]  

  • 5. Extreme Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: Good News or Bad News?
    Kohli U; Saarel EV; Shah M
    Circ Arrhythm Electrophysiol; 2022 May; 15(5):e011033. PubMed ID: 35491875
    [No Abstract]   [Full Text] [Related]  

  • 6. Pattern of left ventricular hypertrophy seen on transthoracic echo in patients with hypertensive cardiomyopathy when compared with idiopathic hypertrophic cardiomyopathy.
    Mirza SJ; Radaideh GA
    J Pak Med Assoc; 2013 Jan; 63(1):16-9. PubMed ID: 23865125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant left ventricular hypertrophy on SPECT imaging in a patient with hypertrophic cardiomyopathy: a comparative image with cardiac magnetic resonance.
    Ghai A; Horn E; Pearson G; Bokhari S
    J Nucl Cardiol; 2005; 12(5):605-6. PubMed ID: 16171721
    [No Abstract]   [Full Text] [Related]  

  • 8. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of imaging in the diagnosis and management of hypertrophic cardiomyopathy.
    Weissler-Snir A; Crean A; Rakowski H
    Expert Rev Cardiovasc Ther; 2016; 14(1):51-74. PubMed ID: 26567960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study.
    Forså MI; Smedsrud MK; Haugaa KH; Bjerring AW; Früh A; Sarvari SI; Landgraff HW; Hallén J; Edvardsen T
    Eur J Prev Cardiol; 2024 Mar; 31(5):591-598. PubMed ID: 37992187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet aggregation in patients with hypertrophic cardiomyopathy].
    Riazanov AS; Gabbasov ZA; Iurenev AP
    Ter Arkh; 2000; 72(8):36-8. PubMed ID: 11019425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients.
    Klues HG; Schiffers A; Maron BJ
    J Am Coll Cardiol; 1995 Dec; 26(7):1699-708. PubMed ID: 7594106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.
    Ho CY; López B; Coelho-Filho OR; Lakdawala NK; Cirino AL; Jarolim P; Kwong R; González A; Colan SD; Seidman JG; Díez J; Seidman CE
    N Engl J Med; 2010 Aug; 363(6):552-63. PubMed ID: 20818890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III.
    Lee PJ; Deanfield JE; Burch M; Baig K; McKenna WJ; Leonard JV
    Am J Cardiol; 1997 Mar; 79(6):834-8. PubMed ID: 9070576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography. Identification by wide-angle two-dimensional echocardiography.
    Maron BJ; Gottdiener JS; Bonow RO; Epstein SE
    Circulation; 1981 Feb; 63(2):409-18. PubMed ID: 6450004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic assessment of left ventricular hypertrophy in patients with obstructive or nonobstructive hypertrophic cardiomyopathy.
    Maron BJ
    Eur Heart J; 1983 Nov; 4 Suppl F():73-91. PubMed ID: 6686547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular hypertrophy in hypertrophic cardiomyopathy: what's in a phenotype?
    Borer JS
    J Am Coll Cardiol; 2004 Jul; 44(2):406-8. PubMed ID: 15261939
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy with progression from apical hypertrophy to asymmetrical septal hypertrophy: a case report.
    Kitaoka H; Kuwahara T; Nishida K; Morimoto K; Kubo T; Okawa M; Furuno T; Doi Y
    J Cardiol; 2005 Apr; 45(4):155-9. PubMed ID: 15875537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitral valve abnormalities in decedents of sudden cardiac death due to hypertrophic cardiomyopathy and idiopathic left ventricular hypertrophy.
    Bhatia RT; Khoury S; Westaby J; Behr ER; Papadakis M; Sharma S; Finocchiaro G; Sheppard MN
    Heart Rhythm; 2022 Oct; 19(10):1684-1685. PubMed ID: 35500788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.